<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04311060</url>
  </required_header>
  <id_info>
    <org_study_id>HEM-3094-19-25-1</org_study_id>
    <nct_id>NCT04311060</nct_id>
  </id_info>
  <brief_title>Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.</brief_title>
  <official_title>Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mexican Agrupation for Hematology Study</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Nacional de Cancerologia de Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Medico Nacional Siglo XXI IMSS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital General de México Dr. Eduardo Liceaga</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Regional de Alta Especialidad del Bajío</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Mexicano del Seguro Social</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Regional de Alta Especialidad de Ciudad Victoria Bicentenario 2010</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Juarez de Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Regional de Alta especialidad de Ixtapaluca</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mexican Agrupation for Hematology Study</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Newly diagnosed adults patients with Acute Myeloid Leukemia will be assessed as traditionally
      by the treating institution using classic clinical, demographic and cytogenetic variables.
      Complementary molecular tests will be performed in the patients included in the study using
      PCR to detect classic CBF (Core Binding Factor) rearrangements: CBFB-MYH11 [inv(16)(p13;q22),
      isoforms A, E and D; AML-ETO (RUNX1-RUNX1T1) (t8;21)(q22;q22). NGS (Next Generation
      Sequencing) to detect mutations in: FLT3-ITD and TKD, NPM1, CEBPA, RUNX1, TP53, ASXL1, IDH1,
      IDH2 and KIT
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 22, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>overall survival</measure>
    <time_frame>3 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Myeloid Leukemia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Molecular panel</intervention_name>
    <description>Detection of CBF rearrangements using PCR: CBFB-MYH11 [inv(16)(p13;q22), isoforms A, E and D; AML-ETO (RUNX1-RUNX1T1) (t8;21)(q22;q22).
NGS panel to detect classic mutations in: FLT3-ITD and TKD, NPM1, CEBPA, RUNX1, TP53, ASXL1, IDH1, IDH2 and KIT</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bone marrow samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Mexican adults with newly diagnosed AML who are candidates for treatment (intensive or not
        intensive)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly diagnosed AML

          -  Over 15 years of age

          -  Flow cytometry confirmation

          -  Candidate for treatment (intensive or not intensive)

        Exclusion Criteria:

          -  Acute Promyelocytic Leukemia

          -  Mixed phenotype leukemias

          -  Isolated myeloid sarcoma

          -  Blastic plasmacytoid dendritic cell neoplasm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Roberta Demichelis, MD</last_name>
    <phone>+521555487 0900</phone>
    <phone_ext>2700</phone_ext>
    <email>robertademichelis@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel Almanza Huante, MD</last_name>
    <email>ealmanza.huante@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Regional de Alta Especialidad Ixtapaluca</name>
      <address>
        <city>Ixtapaluca</city>
        <state>Edo Mex</state>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Alvaro Cabrera García, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Regional de Alta Especialidad Bajío</name>
      <address>
        <city>León</city>
        <state>Guanajuato</state>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Lauro Fabián Amador Medina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrés Gómez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imss Umae 25</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Diego Cruz Contreras, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Regional de Alta Especialidad Ciudad Victoria</name>
      <address>
        <city>Ciudad Victoria</city>
        <state>Tamaulipas</state>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Ramón A Martínez Hernández, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Médico Naciona Siglo XXI IMSS</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Sue Cynthia Gómez Cortes, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de México</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Efreen Montaño Figueroa, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Juarez de México</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrea Milan Salvatierra, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cancerlogía</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <last_name>Silvia Rivas Vera, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name>
      <address>
        <city>Mexico Distrito Federal</city>
        <zip>1400</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 13, 2020</study_first_submitted>
  <study_first_submitted_qc>March 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

